Blackstone Life Sciences Announces $455 Million Heart-Pump Development Collaboration
Blackstone Life Sciences will co-fund development of Boston Scientific’s Vitalyst heart pump for patients with cardiogenic shock.
Related stories
Shanghai Composite Opens 0.4% Lower at 3,624.58
M impact | EQUITY | Nov 03, 2026, 01:30 AM UTC
Hang Seng Tech Index Opens 0.4% Higher at 3853.17
M impact | EQUITY | Nov 03, 2026, 01:28 AM UTC
Hang Seng Index Opens 0.3% Higher at 23469.64
M impact | EQUITY | Nov 03, 2026, 01:28 AM UTC
China's CSI Index Set to Open Down 0.3%
L impact | EQUITY | Nov 03, 2026, 01:28 AM UTC
ChiNext Price Index Opens 1.2% Lower at 2429.77
M impact | EQUITY | Nov 03, 2026, 01:28 AM UTC
Shenzhen Composite Opens 0.6% Lower at 2084.00
M impact | EQUITY | Nov 03, 2026, 01:27 AM UTC